Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.05 USD
Change Today +0.003 / 0.29%
Volume 3.9K
SKBI On Other Exchanges
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark D. Chen

Independent Director, Chairman of Audit Committee and Member of Compensation Committee,Skystar Bio Pharmaceutical Company
AgeTotal Calculated CompensationThis person is connected to 9 board members in 2 different organizations across 3 different industries.

See Board Relationships


Mr. Mark D. Chen serves as Managing Director of Easton Hunt Capital Partners. Mr. Chen has also been Founder and General Partner of Easton Hunt Capital Partners, L.P. since its formation in 1999. He is a Venture Partner at Easton Capital Investment Group. He served as the Chairman, Chief Executive Officer and President of Pantheon China Acquisition, Corp. since April 10, 2006. From January 1997 to December 1997, he served as Chief Operating Officer and was a Co-founder ...

Read Full Background

Corporate Headquarters*

Building B
Xi’an, Shaanxi Province --


Phone: 86 29 8819 3188
Fax: --

Board Members Memberships*

Independent Non-Executive Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Special Committee
Independent Director, Chairman of Audit Committee and Member of Compensation Committee


Columbia Business School
Pennsylvania State University
Shanghai Jiao Tong University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKBI:US $1.05 USD +0.003


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYSTAR BIO-PHARMACEUTICAL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at